Cutaneous sensory and autonomic denervation in progressive supranuclear palsy.
biomarker
epidermal nerve fibres
non-motor symptoms
skin biopsy
tauopathy
Journal
Neuropathology and applied neurobiology
ISSN: 1365-2990
Titre abrégé: Neuropathol Appl Neurobiol
Pays: England
ID NLM: 7609829
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
17
12
2020
received:
18
08
2020
accepted:
28
12
2020
pubmed:
10
1
2021
medline:
1
2
2022
entrez:
9
1
2021
Statut:
ppublish
Résumé
Progressive Supranuclear Palsy (PSP) is a progressive neurodegenerative tauopathy characterised by motor, behavioural and cognitive dysfunction. While in the last decade, sensory and autonomic disturbances as well as peripheral nerve involvement are well-recognised in Parkinson's Disease (PD), little is known in this regard for PSP. Herein, we aim to assess peripheral sensory and autonomic nerve involvement in PSP and to characterise possible differences in morpho-functional pattern compared to PD patients. We studied 27 PSP and 33 PD patients without electrophysiological signs of neuropathy, and 33 healthy controls (HC). In addition to motor impairment, evaluated by means of UPDRS-III and the PSP rating scale, all patients underwent clinical, functional and morphological assessment of sensory-autonomic nerves through dedicated questionnaires, sympathetic skin response, dynamic sweat test and skin biopsies. The analysis of cutaneous sensory and autonomic innervation was performed using indirect immunofluorescence and confocal microscopy. PSP patients displayed a length-dependent loss of sensory and autonomic nerve fibres associated with functional impairment compared to HC and, overall, a more severe picture than in PD patients. The disease severity correlated with the loss of intraepidermal nerve fibre density in the leg of PSP patients (p < 0.05). We demonstrated a length-dependent small fibre pathology in PSP, more severe compared to PD, and paralleling disease severity. Our findings suggest the morphological and functional study of cutaneous nerves as possible biomarkers to monitor disease progression and response to new treatments.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
653-663Informations de copyright
© 2021 British Neuropathological Society.
Références
Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol. 2017;16:552-563.
Höglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32:853-864. https://doi.org/10.1002/mds.26987
Nolano M, Provitera V, Estraneo A, et al. Sensory deficit in Parkinson’s disease: evidence of a cutaneous denervation. Brain. 2008;131:1903-1911. https://doi.org/10.1093/brain/awn102.
Asahina M, Vichayanrat E, Low DA, Iodice V, Mathias CJ. Autonomic dysfunction in Parkinsonian disorders: assessment and pathophysiology. J Neurol Neurosurg Psychiatry. 2013;84:674-680.
Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24:1641-1649. https://doi.org/10.1002/mds.22643
Radicati FG, Martinez Martin P, Fossati C, et al. Non motor symptoms in progressive supranuclear palsy: prevalence and severity. NPJ Park Dis. 2017;3:35. https://doi.org/10.1038/s41531-017-0037-x
Nolano M, Provitera V, Manganelli F, et al. Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients. Neurology. 2017;89:776-784. https://doi.org/10.1212/WNL.0000000000004274
Doppler K, Ebert S, Üçeyler N, et al. Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology. Acta Neuropathol. 2014;128:99-109. https://doi.org/10.1007/s00401-014-1284-0.
Provitera V, Nolano M, Caporaso G, et al. Postganglionic sudomotor denervation in patients with multiple system atrophy. Neurology. 2014;82:2223-2229. https://doi.org/10.1212/WNL.0000000000000518.
Gawel M, Jamrozik Z, Szmidt-Salkowska E, et al. Electrophysiological features of lower motor neuron involvement in progressive supranuclear palsy. J Neurol Sci. 2013;324:136-139. https://doi.org/10.1016/j.jns.2012.10.023.
Doppler K, Weis J, Karl K, et al. Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Mov Disord. 2015;30:1688-1692. https://doi.org/10.1002/mds.26293.
Melli G, Vacchi E, Biemmi V, et al. Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease. Ann Clin Transl Neurol. 2018;5:1394-1407. https://doi.org/10.1002/acn3.669.
Sakakibara R, Hattori T, Tojo M, Yamanishi T, Yasuda K, Hirayama K. Micturitional disturbance in progressive supranuclear palsy. J Auton Nerv Syst. 1993;45:101-106. https://doi.org/10.1016/0165-1838(93)90122-B.
Kikkawa Y, Asahina M, Suzuki A, Hattori T. Cutaneous sympathetic function and cardiovascular function in patients with progressive supranuclear palsy and Parkinson’s disease. Park Relat Disord. 2003;10:101-106. https://doi.org/10.1016/S1353-8020(03)00109-3.
Schmidt C, Herting B, Prieur S, et al. Pupil diameter in darkness differentiates Progressive Supranuclear Palsy (PSP) from other extrapyramidal syndromes. Mov Disord. 2007;22:2123-2126. https://doi.org/10.1002/mds.21721.
Schmidt C, Herting B, Prieur S, et al. Autonomic dysfunction in patients with progressive supranuclear palsy. Mov Disord. 2008;23:2083-2089. https://doi.org/10.1002/mds.22289
Reimann M, Schmidt C, Herting B, et al. Comprehensive autonomic assessment does not differentiate between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. J Neural Transm. 2010;117:69-76. https://doi.org/10.1007/s00702-009-0313-y.
Scaravilli T, Pramstaller PP, Salerno A, et al. Neuronal loss in Onuf’s nucleus in three patients with progressive supranuclear palsy. Ann Neurol. 2000;48:97-101. https://doi.org/10.1002/1531-8249(200007)48:1<97:AID-ANA14>3.0.CO;2-Z
Rub U, Del Tredici K, Schultz C, et al. Progressive supranuclear palsy: Neuronal and glial cytoskeletal pathology in the higher order processing autonomic nuclei of the lower brainstem. Neuropathol Appl Neurobiol. 2002;28:12-22. https://doi.org/10.1046/j.0305-1846.2001.00374.x
Sandroni P, Ahlskog JE, Fealey RD, Low PA. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res. 1991;1:147-155. https://doi.org/10.1007/BF01826212
Kimber J, Mathias CJ, Lees AJ, et al. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain. 2000;123:1422-1430. https://doi.org/10.1093/brain/123.7.1422
Holmberg B, Kallio M, Johnels B, Elam M. Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes. Mov Disord. 2001;16:217-225. https://doi.org/10.1002/mds.1062
Koga S, Aoki N, Uitti RJ, et al. When DLB, PD, and PSP masquerade as MSA. Neurology. 2015;85:404-412. https://doi.org/10.1212/WNL.0000000000001807
van Gerpen JA, Al-Shaikh RH, Tipton PW, et al. Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. Neurology. 2019;93:e1339-e1347. https://doi.org/10.1212/WNL.0000000000008197
Oliveira MCB, Ling H, Lees AJ, Holton JL, De Pablo-Fernandez E, Warner TT. Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 2019;90:555-561. https://doi.org/10.1136/jnnp-2018-319374
Rana AQ, Qureshi AR, Siddiqui O, Sarfraz Z, Rana R, Shtilbans A. Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis. J Neurol. 2019;266:2093-2102.
Goetz CG, Tilley BC, Shaftman SR, et al. Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129-2170. https://doi.org/10.1002/mds.22340
Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 2001;17:427-442. https://doi.org/10.1212/wnl.50.2.318
Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain. 2007;130:1552-1565. https://doi.org/10.1093/brain/awm032
Bakkers M, Merkies I, Lauria G, et al. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology. 2009;73:1142-1148. https://doi.org/10.1212/WNL.0b013e3181bacf05
Visser M, Marinus J, Stiggelbout AM, van Hilten JJ. Assessment of autonomic dysfunction in Parkinson’s disease: The SCOPA-AUT. Mov Disord. 2004;19:306-312. https://doi.org/10.1002/mds.20153.
Kennedy WR, Wendelschafer-Crabb G. The innervation of human epidermis. J Neurol Sci. 1993;115:184-190. https://doi.org/10.1016/0022-510X(93)90223-L
Lauria G, Hsieh ST, Johansson O, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Ner. Eur J Neurol. 2010;17:903-912; e44-e49.
Nolano M, Provitera V, Crisci C, et al. Quantification of myelinated endings and mechanoreceptors in human digital skin. Ann Neurol. 2003;54:197-205. https://doi.org/10.1002/ana.10615
Elfvin LG, Lindh B, Hökfelt T. The chemical neuroanatomy of sympathetic ganglia. Annu Rev Neurosci. 1993;16:471-507.
Nolano M, Provitera V, Donadio V, et al. Cutaneous sensory and autonomic denervation in CADASIL. Neurology. 2016;86:2016. https://doi.org/10.1212/WNL.0000000000002468
Provitera V, Nolano M, Caporaso G, Stancanelli A, Santoro L, Kennedy WR. Evaluation of sudomotor function in diabetes using the dynamic sweat test. Neurology. 2010;74:50-56. https://doi.org/10.1212/WNL.0b013e3181c7da4b
Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69-72. https://doi.org/10.1007/s10286-011-0119-5
Dale ML, Horak FB, Wright WG, Schoneburg BM, Nutt JG, Mancini M. Impaired perception of surface tilt in progressive supranuclear palsy. PLoS One. 2017;12:e0173351. https://doi.org/10.1371/journal.pone.0173351
Dubbioso R, Manganelli F, Siebner HR, Di Lazzaro V. Fast intracortical sensory-motor integration: a window into the pathophysiology of Parkinson’s Disease. Front Hum Neurosci. 2019;13:1-24.
Kofler M, Müller J, Reggiani L, Wenning GK. Somatosensory evoked potentials in progressive supranuclear palsy. J Neurol Sci. 2000;179:85-91. https://doi.org/10.1016/S0022-510X(00)00383-X.
Miwa H, Mizuno Y. Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy. Acta Neurol Scand. 2002;106:209-212. https://doi.org/10.1034/j.1600-0404.2002.01223.x
Avenali M, Tassorelli C, De Icco R, et al. Pain processing in atypical Parkinsonisms and Parkinson disease: a comparative neurophysiological study. Clin Neurophysiol. 2017;128:1978-1984. https://doi.org/10.1016/j.clinph.2017.06.257
Respondek G, Levin J, Höglinger GU. Progressive supranuclear palsy and multiple system atrophy: clinicopathological concepts and therapeutic challenges. Curr Opin Neurol. 2018;31:448-454. https://doi.org/10.1097/WCO.0000000000000581
Kovacs GG, Lukic MJ, Irwin DJ, et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 2020;140:99-119. https://doi.org/10.1007/s00401-020-02158-2
Vitaliani R, Scaravilli T, Egarter-Vigl E, et al. The pathology of the spinal cord in progressive supranuclear palsy. J Neuropathol Exp Neurol. 2002;61:268-274. https://doi.org/10.1093/jnen/61.3.268
Iwasaki Y, Yoshida M, Hashizume Y, Hattori M, Aiba I, Sobue G. Widespread spinal cord involvement in progressive supranuclear palsy. Neuropathology. 2007;27:331-340.
Gibbons GS, Lee VMY, Trojanowski JQ. Mechanisms of cell-to-cell transmission of pathological tau: a review. JAMA Neurol. 2019;76:101-108. https://doi.org/10.1001/jamaneurol.2018.2505
Nishimura M, Namba Y, Ikeda K, Akiguchi I, Oda M. Neurofibrillary tangles in the neurons of spinal dorsal root ganglia of patients with progressive supranuclear palsy. Acta Neuropathol. 1993;85:453-457. https://doi.org/10.1007/BF00230481
Wakabayashi K, Hayashi S, Morita T, Shibasaki Y, Watanabe Y, Takahashi H. Neurofibrillary tangles in the peripheral sympathetic ganglia of non-Alzheimer elderly individuals. Clin Neuropathol. 1999;18:171-175.
Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol. 2010;120:1-12. https://doi.org/10.1007/s00401-010-0706-x
Rodríguez-Leyva I, Chi-Ahumada EG, Carrizales J, et al. Parkinson disease and progressive supranuclear palsy: protein expression in skin. Ann Clin Transl Neurol. 2016;3:191-199. https://doi.org/10.1002/acn3.285
Dugger BN, Hoffman BR, Scroggins A, et al. Tau immunoreactivity in peripheral tissues of human aging and select tauopathies. Neurosci Lett. 2019;696:132-139. https://doi.org/10.1016/j.neulet.2018.12.031
Nolano M, Provitera V, Stancanelli A, et al. Small fiber pathology parallels disease progression in Parkinson disease: a longitudinal study. Acta Neuropathol. 2018;136(3):501-503. https://doi.org/10.1007/s00401-018-1876-1
Nolano M, Provitera V, Lanzillo B, Santoro L. Neuropathy in idiopathic Parkinson disease: an iatrogenic problem? Ann Neurol. 2011;69:427-428.
Picillo M, Cuoco S, Tepedino MF, et al. Motor, cognitive and behavioral differences in MDS PSP phenotypes. J Neurol. 2019;266:1727-1735. https://doi.org/10.1007/s00415-019-09324-x.